HOMEお問い合わせ
ENGLISH
大阪大学 ピアス(皮膚再生技術)共同研究部門
論文
タイトル
発表年
著者、発行誌など
Cinnamtannin B-1 promotes migration of mesenchymal stem cells and accelerates wound healing in mice.

2015

Fujita K, Kuge K, Ozawa N, Sahara S, Zaiki K, Nakaoji K, Hamada K, Taknaka Y, Tanahashi T, Tamai K, Kaneda Y. and Maeda A.

PLoS ONE. 10, 1-17.

Mallotus philippinensis bark extracts promote preferential migration of mesenchymal stem cells and improve wound healing in mice.

2014

Furumoto T, Ozawa N, Inami Y, Toyoshima M, Fujita K, Zaiki K, Sahara S., Akita M., Kitamura K., Nakaoji K., Hamada K., Tamai K., Kaneda Y. and Maeda A.
Phytomedicine. 21, 247–253.
HIG1, a novel regulator of mitochondrial γ-secretase, maintains normal mitochondrial function.
2012

Hayashi H, Nakagami H, Takeichi M, Shimamura M, Koibuchi N, Oiki E, Sato N, Koriyama H, Mori M, Gerardo Araujo R, Maeda A, Morishita R, Tamai K. and Kaneda Y.

FASEB J. 26, 2306-2317.

Modification of a novel angiogenic peptide, AG-30, for the development of novel therapeutic agents.
2011

Nakagami H, Nishikawa T, Tamura N, Maeda A, Hibino H, Mochizuki M, Shimosato T, Moriya T, Morishita R, Tamai K, Tomono K. and Kaneda Y.

J. Cell. Mol. Med. 16, 1629-1639.

Development of a novel antimicrobial peptide, AG-30, with angiogenic properties.
2009
Nishikawa T, Nakagami H, Maeda A, Morishita R, Miyazaki N, Ogawa T, Tabata Y, Kikuchi Y, Hayashi H, Tatsu, Yumoto N, Tamai K, Tomono K and Kaneda Y.
J. Cell. Mol. Med. 13, 535-546.
New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin.
2008
Kawano H, Komaba S, Ymazaki T, Maeda M, Kimura Y, Maeda A and Kaneda Y.
Cancer Chemother Phamacol. 61, 973-978.
Development of high throughput functional screening of therapeutic genes using HVJ-E vector.
2006
Nishikawa T, Nakagami H, Matsuki A, Maeda A, Yo CY, Harada T, Morishita R, Tamai K, Kaneda Y.
Hum Gene Ther. 4, 470-475.
RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1.
2003
Katagiri K., Maeda A., Simonaka M., and Kinashi T.
Nature Immunol. 4, 741-748.
A role for SHPS-1/SIRPalpha1 in IL-1beta- and TNFalpha-dependent signaling.
2002
Ruhul Amin AR., Machida K., Oshima K., Oo ML., Thant AA., Senga T., Matsuda S., Akhand AA., Maeda A., Kurosaki T., and Hamaguchi M.
Oncogene 57, 8871-8878.
Cbl-b positively regulates Btk-mediated activation of phospholipase C-γ2 in B cells.
2002
Yasuda, T., Tezuka, T. , Maeda, A., Inazu, T., Yamanashi, Y. , Gu, H., Kurosaki, T.and Yamamoto, T.
J. Exp. Med. 196, 51-63.
The B lymphocyte adaptor molecule of 32 kilodaltons (Bam32) regulates B cell antigen receptor signaling and cell survival.
2002
Niiro, H., Maeda, A., Kurosaki, T. and Clark, E.A.
J. Exp. Med. 195,143-149.
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
2001
Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T. and Honjo, T.
Proc. Natl. Acad. Sci. USA. 98, 13866-13871.
Biliary glycoprotein (BGPa, CD55a, CEACAM1) mediates inhibitory signals.
2001
Chen, T., Zimmermann, W., Parker, J., Chen, I., Maeda, A. and Bolland, S.
J. Leukocyte. Biol. 70, 335-340.
BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation.
2000
Okada, T., Maeda A., Iwamatsu A., Gotoh K.and Kurosaki T.
Immunity. 13, 817-827.
Cbl suppresses B cell receptor-mediated Phospholipase C (PLC)-γ2 activation by regulating B cell linker protein-PLC-γ2 binding.
2000
Yasuda, T., Maeda, A., Kurosaki, M., Tezuka, T., Hironaka, K., Yamamoto, T. and Kurosaki, T.
J. Exp. Med.191, 641-650.
Molecular cloning and functional characterization of a novel receptor-activated TRP Ca2+ channel from mouse brain.
1999
Okada, T., Shimizu, S., Wakamori, M., Maeda, A., Kurosaki, T., Takada, N., Imoto, K. and Mori, Y.
J. Biol. Chem. 274, 27359-27370.
Paired Immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1.
1999
Maeda, A., Scharenberg, A.M., Tsukada, S., Bolen, J.B., Kinet, J-P. and Kurosaki, T.
Oncogene 18, 2291-2297.
Encoding of Ca signals by differential expression of IP3 receptor subtypes.
1999
Miyakawa, T., Maeda, A., Yamazawa, T., Hirose, K., Kurosaki, T. and Iino, M.
EMBO.J. 5, 1303-1308.
PIR-A is involved in activating mast cells through its association with FcRγ chain.
1998
Maeda, A., Kurosaki, M. and Kurosaki, T.
J. Exp. Med. 188, 991-995.
Molecular cloning and functional characterization of a novel receptor-activated TRP Ca2+ channel from mouse brain.
1998
Okada, T., Shimizu, S., Wakamori, M., Maeda, A., Kurosaki, T., Takada, N., Imoto, K. and Mori, Y.
J. Biol. Chem. 273, 10279-10287.
Requirement of tyrosine phosphatse SHP-1 and SHP-2 for PIR-B-mediated inhibitory signal.
1998
Maeda, A., Kurosaki, M., Ono, M., Takai, T. and Kurosaki, T.
J. Exp. Med. 187, 1355-1360.
Molecular cloning and characterization of a human brain ryanodine receptor.
1997
Nakashima, Y., Nishimura, S., Maeda, A., Barsoumian, E.L., Hakamata, Y., Nakai, J., Allen, P.D., Imoto, K., Kita, T.
FEBS Letters 417, 157-162.
Generation of cell transfectants expressing cardiac calcium ion channel and calcium indicator protein, aequorin.

1996

Maeda, A., Nishimura, S., Kameda, K., Imagawa, T., Sigekawa, M., Barsoumian, E.L.
Anal. Biochem. 242, 31-39.
Different sensitivities to agonist of muscarinic acetylcholine receptor subtypes.
1988
Bujo, H., Nakai, J., Kubo, T., Fukuda, K., Akiba, I., Maeda, A., Mishina, M. and Numa, S.
FEBS Letters 240, 95-100.
Tissue distribution of mRNAs encoding muscarinic acetylcholine receptor subtypes.
1988
Maeda, A., Kubo, T., Mishina, M. and Numa, S.
FEBS Letters 239, 339-342.
Selective coupling with K+ currents of muscarinic acetylcholine receptor subtypes in NG108-15 cells.
1988
Fukuda, K., Higashida, H., Kubo, T., Maeda, A., Akiba, I., Bujo, H., Mishina, M. and Numa, S.
Nature 335, 355-358.
Primary structure of porcine muscarinic acetylcholine receptor III and antagonist binding studies.
1988
Akiba, I., Kubo T., Maeda A., Bujo H., Nakai J., Mishina M. and Numa S.
FEBS Letters 235, 257-261.
Molecular distinction between muscarinic acetylcholine receptor subtypes.
1987
Fukuda, K., Kubo, T., Akiba, I., Maeda, A., Mishina, M. and Numa, S.
Nature 327, 623-625.
Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence.
1986
Kubo, T., Maeda, A., Sugimoto, K., Akiba, I., Mikami, A., Haga, T., Haga, K., Ichiyama, A., Kangawa, K., Matsuo, H., Hirose, T. and Numa, S.
FEBS Letters 209, 367-372.
Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor.
1986
Kubo, T., Fukuda, K., Mikami, A., Maeda, A., Takahashi, H., Mishina, M., Haga, T., Haga, K., Ichiyama, A., Kangawa, K., Kojima, M., Matsuo, H., Hirose, T. and Numa, S.
Nature 323, 411-416.
Monoclonal anti-Fcε receptor antibodies with different specificities and studies on the expression of Fcε receptors on human B and T cells.
1986
Suemura, M., Kikutani, H., Barsoumian, E. L., Hattori, Y., Kishimoto, S., Sato, R., Maeda, A., Nakarura, H., Owaki, H., Hardy, R. R. and Kishimoto,T.
J. Immunol. 137, 1214-1220.
著書
タイトル
発表年
著者、出版
免疫学辞典
(分担/PIR, co-receptor)
2001 前田明人著 東京化学同人 
Activating and Inhibitory Immunoglobulin-like Receptors
(分担/ Molecular mechanism of Paired Immunoglobulin-like receptor B (PIR-B)-
mediated inhibitory signal)
2001 Akito Maeda 、 Scharenberg, A.M., Tsukada, S., Bolen, J.B., Kinet, J-P. and Kurosaki, T. 著 
Springer
臨床免疫別冊 免疫担当細胞上の細胞表面分子とその機能
(分担/PIR)
2000 前田明人著 
シグナル伝達ネットワーク 
(分担/B細胞抗原受容体を介するシグナルネットワーク)
2000 前田明人、黒崎知博共著 
東京化学同人
BioScience用語ライブラリー、細胞内シグナル伝達改訂第2版 
(分担/2章(26)SHPー1、SHPー2)
1999 前田明人著 
羊土社
免疫1998ー1999
(分担/FcγRIIB, PIR-Bを介したネガティブシグナル)
1998 前田明人、黒崎知博共著 
中山書店
特許
名称 概要
特願2007-29945 血管新生誘導剤及びそれに用いられるポリペプチド
特願2007-29920 新規ポリペプチド及びそれを有効成分として含有する抗菌剤
特願2006-039246 CMYA5遺伝子に存在する遺伝子多型と疾患の診断のための検出方法
特願2004-081748 細胞培養用マイクロウェル
特願2004-81728 ウィルスベクターによる固相遺伝子導入方法、その方法のための組成物、およびその方法のための装置
特願2001-177577 p85との結合活性を有するタンパク質、およびそのタンパク質をコードする核酸等